NASDAQ •
Healthcare •
Medical Devices •
Quote as of 06/22/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3.41 mln
Float2.36 mln
Earnings Date08/12/2026
Piotroski F-Score
4
/ 9
Borderline
1-Year Forecast
3.25
Transformational upside
Relative Strength
3
/ 100
Severely lagging
Debt / Equity
0.07
Debt-free
ROE
-138
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Founded in 1984 and headquartered in San Diego, California, Aethlon Medical is working to bring a new kind of treatment device to patients fighting cancer or dangerous viral infections. The company's main product, the Hemopurifier, is currently in clinical trials and is also being explored for use in organ transplantation. By filtering harmful agents from the blood, this device aims to support the body's natural ability to fight disease.
